The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Novo Nordisk A/S

NYSE: NVO
Last

(U.S.) $47.75

Today's change+0.22 +0.46%
Updated February 27 4:04 PM EST. Delayed by at least 15 minutes.
 

Novo Nordisk A/S

NYSE: NVO
Last

(U.S.) $47.75

Today's change+0.22 +0.46%
Updated February 27 4:04 PM EST. Delayed by at least 15 minutes.

Novo Nordisk A/S Hits New 100-day High

Novo Nordisk A/S closed up Friday by (U.S.)$0.22 or 0.46% to (U.S.)$47.75 and setting a new 100-day high. Over the last five days, shares have gained 0.42% and are currently 2.76% off of the 52-week high. Shares have underperformed the S&P 500 by 12.52% during the last year.

Key company metrics

  • Open(U.S.) $47.40
  • Previous close(U.S.) $47.53
  • High(U.S.) $48.03
  • Low(U.S.) $47.35
  • Bid / Ask-- / --
  • YTD % change+12.83%
  • Volume1,046,418
  • Average volume (10-day)1,519,468
  • Average volume (1-month)1,411,363
  • Average volume (3-month)1,367,063
  • 52-week range(U.S.) $41.72 to (U.S.) $49.11
  • Beta0.97
  • Trailing P/E32.37×
  • P/E 1 year forward24.76×
  • Forward PEG1.71×
  • Indicated annual dividend(U.S.) $0.76
  • Dividend yield1.59%
  • Trailing EPS(U.S.) $1.48
Updated February 27 4:04 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+30.27%

Based on its net profit margin of 30.27%, Novo Nordisk A/S is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.04%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue22,24921,62920,34321,698
Total other revenue--------
Total revenue22,24921,62920,34321,698
Gross profit18,82317,95816,87718,298
Total cost of revenue3,4263,6713,4663,400
Total operating expense13,68012,89612,31014,344
Selling / general / administrative6,7696,3545,8917,557
Research & development3,6543,0753,1683,566
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total-169-204-215-179
Operating income8,5698,7338,0337,354
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax8,4548,9898,3017,790
Income after tax6,5006,9946,4586,053
Income tax, total1,9541,9951,8431,737
Net income6,5006,9946,4586,053
Total adjustments to net income--------
Net income before extra. items6,5006,9946,4586,053
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items6,5006,9946,4586,053
Inc. avail. to common incl. extra. items6,5006,9946,4586,053
Diluted net income6,5006,9946,4586,053
Dilution adjustment--0----
Diluted weighted average shares2,6222,6372,6532,666
Diluted EPS excluding extraordinary itemsvalue per share2.482.652.432.27
Dividends per sharevalue per share0.000.000.003.35
Diluted normalized EPSvalue per share2.482.652.432.27